Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
How ToolGen met Cartherics
By Christine Filippis / September 16, 2019
To borrow from Louis Pasteur, ‘collaboration’ favours the prepared mind … and networking helps, as ToolGen’s Jae Young Lee well...
Read More
Registrations now open !! : Eradicate Cancer 2020 Next frontiers in immunotherapy
By Christine Filippis / September 13, 2019
https://www.eradicatecancer2020.org We are excited to announce that registrations & abstract submissions for Eradicate Cancer 2020 are now open! The field of...
Read More
Australian Scientist wins “America’s Nobels”
By Christine Filippis / September 10, 2019
Congratulations to Cartherics' Scientific Advisor Jacques Miller. He co-shares the 2019 Lasker Award for medical research. Australian scientist, Professor Jacques...
Read More
